Literature DB >> 18790573

Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal.

Yadira Ibarguen-Vargas1, Alexandre Surget, Chadi Touma, Rupert Palme, Catherine Belzung.   

Abstract

Etiopathogenesis of depression and the cause of insensitivity to treatment remain poorly understood, although genetic makeup has been established as a contributing factor. The isogenicity of inbred mouse strains provides a useful tool for investigating the link between genes and behavior or drug response. Hence, our aim was to identify inbred mouse strains (among A/J, BALB/c, C3H, C57BL/6, CBA, DBA and FVB) sensitive to a 9-week period of unpredictable chronic mild stress (UCMS) and, from the fifth week onward, to the reversal effect of an antidepressant (AD) (imipramine, 20mg/kg/day i.p.) on various depression-related changes: physical, behavioral and neuroendocrine states. UCMS induced a significant deterioration of the coat state (in all the strains), blunted emotional reactivity in the novelty-suppressed feeding (NSF) test (A/J, BALB/c, C57BL/6), and changes in the level of fecal corticosterone metabolites (BALB/c, C57BL/6, DBA, FVB). Imipramine treatment reversed the UCMS-induced alterations of the coat state (BALB/c, DBA), in the NSF test (A/J, BALB/c, C57BL/6) and in fecal corticosterone metabolites (BALB/c, C57BL/6). C3H, CBA and FVB mice were irresponsive to imipramine treatment. It is noteworthy that UCMS-induced physical or behavioral changes occurred without hypothalamo-pituitary-adrenal (HPA) axis alterations in some strains (A/J, C3H, CBA), although the AD-induced reversal of these changes in BALB/c and C57BL/6 was associated with HPA axis normalization. Finally, UCMS is shown to discriminate various alterations and to replicate in a strain-dependent manner diverse profiles reminiscent of human disease subtypes. UCMS may thus enable the selection of strains suitable for investigating specific depression-related features and could be an appropriate model for identifying genetic factors associated with increased vulnerability, specific symptoms of affective disorders, and AD resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790573     DOI: 10.1016/j.psyneuen.2008.07.010

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  39 in total

1.  The calm mouse: an animal model of stress reduction.

Authors:  Blake T Gurfein; Andrew W Stamm; Peter Bacchetti; Mary F Dallman; Nachiket A Nadkarni; Jeffrey M Milush; Chadi Touma; Rupert Palme; Charles Pozzo Di Borgo; Gilles Fromentin; Rachel Lown-Hecht; Jan Pieter Konsman; Michael Acree; Mary Premenko-Lanier; Nicolas Darcel; Frederick M Hecht; Douglas F Nixon
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

2.  Impact of Genetic Variation on Stress-Related Ethanol Consumption.

Authors:  Megan K Mulligan; Lu Lu; Sonia A Cavigelli; Pierre Mormède; Elena Terenina; Wenyuan Zhao; Robert W Williams; Byron C Jones
Journal:  Alcohol Clin Exp Res       Date:  2019-05-21       Impact factor: 3.455

3.  Social isolation reduces mammary development, tumor incidence, and expression of epigenetic regulators in wild-type and p53-heterozygotic mice.

Authors:  Nina S Hasen; Kathleen A O'Leary; Anthony P Auger; Linda A Schuler
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-27

4.  Glutamatergic mechanisms associated with stress-induced amygdala excitability and anxiety-related behavior.

Authors:  Sophie Masneuf; Emily Lowery-Gionta; Giovanni Colacicco; Kristen E Pleil; Chia Li; Nicole Crowley; Shaun Flynn; Andrew Holmes; Thomas Kash
Journal:  Neuropharmacology       Date:  2014-05-04       Impact factor: 5.250

5.  Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice.

Authors:  Jessica L Ihne; Paul J Fitzgerald; Kathryn R Hefner; Andrew Holmes
Journal:  Neuropharmacology       Date:  2011-09-02       Impact factor: 5.250

6.  An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents.

Authors:  Jefferson C Frisbee; Steven D Brooks; Shyla C Stanley; Alexandre C d'Audiffret
Journal:  J Vis Exp       Date:  2015-12-02       Impact factor: 1.355

7.  Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice.

Authors:  Elsa Isingrini; Vincent Camus; Anne-Marie Le Guisquet; Maryse Pingaud; Séverine Devers; Catherine Belzung
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

8.  Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine.

Authors:  Bruna Cuccurazzu; Valeria Bortolotto; Maria Maddalena Valente; Federica Ubezio; Aleardo Koverech; Pier Luigi Canonico; Mariagrazia Grilli
Journal:  Neuropsychopharmacology       Date:  2013-05-14       Impact factor: 7.853

9.  Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Nieves Herrera-Mundo; Catherine E Sykes; Dina M Francescutti; Donald M Kuhn
Journal:  ACS Chem Neurosci       Date:  2014-08-12       Impact factor: 4.418

10.  Chronic mild stress (CMS) in mice: of anhedonia, 'anomalous anxiolysis' and activity.

Authors:  Martin C Schweizer; Markus S H Henniger; Inge Sillaber
Journal:  PLoS One       Date:  2009-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.